Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic and Viral Characteristics and Response to Dual and Extended Antiviral Therapy

Dual/extended antiviral therapy with nirmatrelvir/r and remdesivir can be effective for protracted SARS-CoV-2 infection in B-cell-depleted patients who fail antiviral monotherapy, despite persistently blunted humoral immune responses. Additionally, immunocompromised hosts are at risk of both protracted infection and early re-infection, which can be differentiated by viral sequencing.

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2025-07-16
DOI
https://doi.org/10.1093/cid/ciaf383
Citations
4
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
5.58
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic and Viral Characteristics and Response to Dual and Extended Antiviral Therapy

Nicolas C. Issa, Hannah Levine, Rinki Deo, Muneerah M Aleissa et al.
4 citations
Clinical Infectious Diseases
SARS-CoV-2 and COVID-19 Research
5.58
article

Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic and Viral Characteristics and Response to Dual and Extended Antiviral Therapy

Nicolas C. Issa, Hannah Levine, Rinki Deo, Muneerah M Aleissa, Meghan A. Baker, Zoe Swank, Ella Borberg, Jonathan Z. Li, Pritha Sen, Hayden S Andrews, Amy C Sherman, Kenneth J. Friedman, Scott Dryden‐Peterson, Ann E. Woolley, Jessica S Little, Manish C. Choudhary, Cameron T. Nutt, Lisa A. Cosimi, David R. Walt, Lindsey Robert Baden, Urwah Kanwal, Xiaofang Li, Gregory E. Edelstein, Anna Piermattei, Aidan Eustace
article en
4 citations

Abstract

Dual/extended antiviral therapy with nirmatrelvir/r and remdesivir can be effective for protracted SARS-CoV-2 infection in B-cell-depleted patients who fail antiviral monotherapy, despite persistently blunted humoral immune responses. Additionally, immunocompromised hosts are at risk of both protracted infection and early re-infection, which can be differentiated by viral sequencing.

Clinical Infectious DiseasesVol. 81(6)
Princess Nourah bint Abdulrahman University (SA), Brigham and Women's Hospital (US), Harvard University (US), Dana-Farber Cancer Institute (US), Inspire Institute (US)
Good health and well-being
Openalex Percentile: Top 4%
SARS-CoV-2 and COVID-19 Research
5.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.